Finance

Beta
Lists
002755:SHE
Beijing Aosaikang Pharmaceutical Co Ltd
CN¥12.92
-0.77%
(-0.10) 1D
Jun 5, 3:04:45 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002755...
Open
CN¥13.15
High
CN¥13.29
Low
CN¥12.92
Mkt. cap
12.08B
Avg. vol.
19.31M
Volume
10.32M
P/E ratio
45.02
52-wk high
CN¥29.00
52-wk low
CN¥12.92
EPS
CN¥0.29
Shares outstanding
928.16M
No. of employees
799
Open
CN¥13.15
High
CN¥13.29
Low
CN¥12.92
Mkt. cap
12.08B
Avg. vol.
19.31M
Volume
10.32M
P/E ratio
45.02
52-wk high
CN¥29.00
52-wk low
CN¥12.92
EPS
CN¥0.29
Shares outstanding
928.16M
No. of employees
799
News stories
From sources across the web
About Beijing Aosaikang Pharmaceutical Co Ltd
CEO-
Employees799
Founded1978
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
498.86M
426.48M
345.13M
481.78M
Cost of goods sold
96.07M
104.64M
63.62M
76.60M
Cost of revenue
96.07M
104.64M
63.62M
76.60M
Research and development expenses
31.42M
24.80M
43.39M
26.24M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
276.34M
245.93M
211.23M
271.28M
Operating expense
316.07M
240.44M
295.08M
300.50M
Total operating expenses
412.14M
345.08M
358.70M
377.10M
Operating income
86.72M
81.40M
-13.57M
104.68M
Other non operating income
-1.71M
936.04K
1.76M
273.08K
EBT including unusual items
98.71M
64.12M
38.49M
112.80M
EBT excluding unusual items
92.62M
80.66M
-7.60M
108.10M
Income tax expense
2.32M
3.90M
32.42M
8.92M
Effective tax rate
2.35%
6.08%
84.22%
7.91%
Other operating expenses
6.92M
-29.70M
40.68M
5.15M
Net income
105.26M
63.33M
13.29M
84.47M
Net profit margin
21.10%
14.85%
3.85%
17.53%
Earnings per share
-
-
-
-
Interest and investment income
7.31M
-
3.63M
4.33M
Interest expense
-322.90K
-1.05M
-99.07K
-1.18M
Net interest expenses
6.98M
-1.05M
3.53M
3.15M
Depreciation and amortization charges
-
-
-
-
EBITDA
117.61M
100.22M
17.89M
136.14M
Gain or loss from assets sale
-
-
27.23K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more